BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21681602)

  • 1. Correlation analysis of JAK-STAT pathway components on prognosis of patients with prostate cancer.
    Liu X; He Z; Li CH; Huang G; Ding C; Liu H
    Pathol Oncol Res; 2012 Jan; 18(1):17-23. PubMed ID: 21681602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma.
    You Z; Xu D; Ji J; Guo W; Zhu W; He J
    Clin Transl Oncol; 2012 Feb; 14(2):143-9. PubMed ID: 22301404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors.
    Kondyli M; Gatzounis G; Kyritsis A; Varakis J; Assimakopoulou M
    J Neurooncol; 2010 Nov; 100(2):157-64. PubMed ID: 20336349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.
    Takayama H; Nonomura N; Nishimura K; Oka D; Shiba M; Nakai Y; Nakayama M; Tsujimura A; Aozasa K; Okuyama A
    BJU Int; 2009 Feb; 103(4):470-4. PubMed ID: 18778349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.
    Denley SM; Jamieson NB; McCall P; Oien KA; Morton JP; Carter CR; Edwards J; McKay CJ
    J Gastrointest Surg; 2013 May; 17(5):887-98. PubMed ID: 23435739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of phosphorylated-signal transduction and activators of transcription 3 in detecting prostate cancer from negative biopsies.
    Han G; Yu JY; Chen YD; Cao XL; Zhu J; Wang W; Wang XX; Zhang X; Yan JQ; Gao JP
    Eur J Surg Oncol; 2012 Apr; 38(4):367-73. PubMed ID: 22261084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear expression of pSTAT3
    Marginean FE; Hellsten R; Krzyzanowska A; Bjartell A
    Pathol Res Pract; 2022 Apr; 232():153811. PubMed ID: 35259550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer.
    Tam L; McGlynn LM; Traynor P; Mukherjee R; Bartlett JM; Edwards J
    Br J Cancer; 2007 Aug; 97(3):378-83. PubMed ID: 17595657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between PI3K, JAK/STAT pathways with the PDL-1 expression in prostate cancer.
    Kazan O; Kir G; Culpan M; Cecikoglu GE; Atis G; Yildirim A
    Andrologia; 2022 Nov; 54(10):e14541. PubMed ID: 35880672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of JAK/STAT signalling in neurons following spinal cord injury in mice.
    Yamauchi K; Osuka K; Takayasu M; Usuda N; Nakazawa A; Nakahara N; Yoshida M; Aoshima C; Hara M; Yoshida J
    J Neurochem; 2006 Feb; 96(4):1060-70. PubMed ID: 16417589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis.
    Tao J; Mariani L; Eddy S; Maecker H; Kambham N; Mehta K; Hartman J; Wang W; Kretzler M; Lafayette RA
    Kidney Int; 2018 Oct; 94(4):795-808. PubMed ID: 30093081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
    Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
    Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.
    Zhang H; Qi C; Wang A; Yao B; Li L; Wang Y; Xu Y
    J Exp Clin Cancer Res; 2013 Oct; 32(1):77. PubMed ID: 24422979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of Her-2/neu and clinicopathologic factors for evaluating progression and disease-specific death in Chinese men with prostate cancer.
    Zhang YF; Guan YB; Yang B; Wu HY; Dai YT; Zhang SJ; Wang JP; Anoopkumar-Dukie S; Davey AK; Sun ZY
    Chin Med J (Engl); 2011 Dec; 124(24):4345-9. PubMed ID: 22340411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
    Agarwal C; Tyagi A; Kaur M; Agarwal R
    Carcinogenesis; 2007 Jul; 28(7):1463-70. PubMed ID: 17341659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic characteristics and prognosis of early onset prostate cancer].
    Wang Y; Du SJ; Zhang JX; He HY
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):373-377. PubMed ID: 28591982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on correlation of JAK/STAT signal pathway with progression and prognosis in hepatocellular carcinoma].
    Zhang B; Zhong DW; Wang QW; Miao XY; Dai WD; Liu C; Pan KH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):368-70, 373. PubMed ID: 20368117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum β2-microglobulin levels with prostate-specific antigen, Gleason score, clinical stage, tumor metastasis and therapy efficacy in prostate cancer.
    Zhang YX; Wang L; Ji PY; Zhao GG; Zhong GP; Wang ZP
    Arch Med Res; 2013 May; 44(4):259-65. PubMed ID: 23707648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
    García-Cruz E; Piqueras M; Huguet J; Peri L; Izquierdo L; Musquera M; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
    BJU Int; 2012 Dec; 110(11 Pt B):E541-6. PubMed ID: 22584031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.